Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-24T23:05:02.408Z Has data issue: false hasContentIssue false
  • English
  • Français

Arginine vasopressin in manic-depressive psychosis

Published online by Cambridge University Press:  09 July 2009

M. D. Penney ,
M. J. Levell  and
R. P. Hullin
M. D. Penney
Affiliation:
Regional Metabolic Research Unit, High Royds Hospital, Ilkley, Division of Steroid Endocrinology, University of Leeds
M. J. Levell
Affiliation:
Regional Metabolic Research Unit, High Royds Hospital, Ilkley, Division of Steroid Endocrinology, University of Leeds
R. P. Hullin*
Affiliation:
Regional Metabolic Research Unit, High Royds Hospital, Ilkley, Division of Steroid Endocrinology, University of Leeds
*
1Address for correspondence: Dr R. P. Hullin, Regional Metabolic Research Unit, High Royds Hospital, Menston, Ilkley, West Yorkshire, LS29 6AQ.
Get access Rights & Permissions [Opens in a new window]

Synopsis

Urinary excretions of arginine vasopressin (AVP), sodium, potassium, osmoles and creatinine were measured in three in-patients with bipolar manic-depressive psychosis on at least eight 24-hour periods in each affective phase. Mood and body weight were recorded twice daily. The excretion by each patient of sodium, water and osmoles was greater in mania than during depression. Comparison of electrolytes and osmoles suggested that the increase was due to increased intake of salt and water rather than of total diet. There was a fall of mean AVP excretion during mania, the magnitude of the fall being related to the increase of water throughput.

Compared with controls, AVP excretion was high and variable. It did not show the normal relationship to urine osmolality. Days with very high AVP were not associated with any characteristic feature of the other measurements; nor were they confined to any one point in the manic-depressive cycle.

AVP does not appear to play a major role in the salt and water changes characteristic of manicdepressive psychosis and we have no evidence of its having any direct relationship to mood changes. We suggest that the observed abnormalities of AVP excretion are another manifestation of the central defect of this disease.

Type
Research Article
Information
Psychological Medicine , Volume 17 , Issue 4 , November 1987 , pp. 861 - 867
Copyright
Copyright © Cambridge University Press 1987

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Allers, R. (1914). Ergebnisse Stoffwechselpathologischer Untersuchungen bei Psychosen. III Das Manisch-depressive Irresein. Zeitschrift für die Gesamte Neurologie und Psychiatrie 9, 585–625.Google Scholar
Cornbleet, P. J. & Gochman, N. (1979). Incorrect least-squares regression coefficients in method-comparison analysis. Clinical Chemistry 25, 432–438.CrossRefGoogle ScholarPubMed
Crammer, J. L. (1959). Water and sodium in two psychotics. Lancet i, 1122–1126.CrossRefGoogle Scholar
Gibbons, J. L. (1963). Electrolytes and depressive illness. Postgraduate Medical Journal 39, 19–25.CrossRefGoogle ScholarPubMed
Gold, P. W., Goodwin, F. K. & Reus, V. I. (1978) Vasopressin in affective illness. Lancet i, 1233–1236.CrossRefGoogle Scholar
Gold, P. W., Goodwin, F. K., Post, R. M. & Robertson, G. L. (1981). Vasopressin function in depression and mania. Pharmacology Bulletin 17, 7–9.Google ScholarPubMed
Goodwin, J. C. & Jenner, F. A. (1967). The cyclical excretion of a sodium thioglycollate-resistant antidiuretic factor by a periodic psychotic. Journal of Endocrinology 38, XXIV.Google Scholar
Hullin, R. P. (1979). Minimum effective plasma lithium levels for long-term preventive treatment of recurrent affective disorders.In: Lithium Controversies and Unresolved Issues. Proceedings of the International Lithium Conference (ed Cooper, T. B., Gershon, S., Kline, N. S. and Schou, M.), pp. 333–334. Excerpta Medica: Amsterdam.Google Scholar
Hullin, R. P., Coley, V. P., Birch, N. J., Morgan, D. B. & Thomas, T. H. (1979). The renal function of patients after long-term treatment with lithium. British Medical Journal i, 1457–1459.CrossRefGoogle Scholar
Morgan, D. B., Penney, M. D., Hullin, R. P., Thomas, T. H. & Srinivasan, D. P. (1982). The responses to water deprivation in lithium-treated patients with and without polyuria. Clinical Science 63, 549–554.CrossRefGoogle ScholarPubMed
O'Connor, W. J. (1962). Renal Function. Arnold: London.Google Scholar
Penney, M. D., Hullin, R. P., Srinivasan, D. P. & Morgan, D. B. (1981). The relationship between plasma lithium and the renal responsiveness to arginine vasopressin in man. Clinical Science 61, 793–795.CrossRefGoogle ScholarPubMed
Rees, J. R., Allsopp, M. N E. & Hullin, R. P. (1974). Plasma concentrations of tryptophan and other amino acids in manicdepressive patients. Psychological Medicine 4, 334–337.CrossRefGoogle ScholarPubMed
Robertson, G. L. (1977). The regulations of vasopressin function in health and disease. Recent Progress in Hormone Research 33, 333–385.Google Scholar
Thomas, T. H. & Lee, M. R. (1976). The specificity of antisera for the radioimmunoassay of arginine-vasopressin in human plasma and urine during water loading and dehydration. Clinical Science and Molecular Medicine 51, 525–536Google ScholarPubMed